Supersolid state in fermionic optical lattice systems

We study ultracold fermionic atoms trapped in an optical lattice with harmonic confinement by combining the real-space dynamical mean-field theory with a two-site impurity solver. By calculating the local particle density and the pair potential in the systems with different clusters, we discuss the stability of a supersolid state, where an s-wave superfluid coexists with a density-wave state of checkerboard pattern. It is clarified that a confining potential plays an essential role in stabilizing the supersolid state. The phase diagrams are obtained for several effective particle densities.Comment: 7 pages, 5 figures, Phys. Rev. A in pres

Finite-temperature Mott transitions in multi-orbital Hubbard model

We investigate the Mott transitions in the multi-orbital Hubbard model at half-filling by means of the self-energy functional approach. The phase diagrams are obtained at finite temperatures for the Hubbard model with up to four-fold degenerate bands. We discuss how the first-order Mott transition points $U_{c1}$ and $U_{c2}$ as well as the critical temperature $T_c$ depend on the orbital degeneracy. It is elucidated that enhanced orbital fluctuations play a key role to control the Mott transitions in the multi-orbital Hubbard model.Comment: 8 pages, 7 figure

Metalorganic chemical vapor deposition of β-FeSi2 on β-FeSi2 seed crystals formed on Si substrates

We have fabricated a β-FeSi2 film by metalorganic chemical vapor deposition on a Si(001) substrate with β-FeSi2 seed crystals grown by molecular beam epitaxy, and investigated the crystallinity, surface morphology and temperature dependence of photoresponse properties of the β-FeSi2 film. The surface of the grown β-FeSi2 film was atomically flat, and step-and-terrace structure was clearly observed. Multi-domain structure of β-FeSi2 whose average size was approximately 200 nm however was revealed. The photoresponse was obtained in an infrared light region (~ 0.95 eV) at temperatures below 200 K. The external quantum efficiency reached a maximum, being as large as 25% at 100 K when a bias voltage was 2.0 V

Anaplastic carcinoma of the pancreas producing granulocyte-colony stimulating factor: a case report

<p>Abstract</p> <p>Introduction</p> <p>The granulocyte-colony stimulating factor-producing tumor was first reported in 1977, however, anaplastic pleomorphic type carcinoma of the pancreas producing granulocyte-colony stimulating factor is still rare.</p> <p>Case presentation</p> <p>A 63-year-old man was admitted to our hospital with body weight loss (-10 kg during months) and upper abdominal pain from 3 weeks. Abdominal computed tomography demonstrated a pancreatic tumor 10 cm in size and multiple low-density areas in the liver. On admission, the peripheral leukocyte count was elevated to 91,500/mm³and the serum concentration of granulocyte-colony stimulating factor was 134 pg/mL (normal, < 18.1 pg/mL). Based on liver biopsy findings, the tumor was classified as an anaplastic pleomorphic-type carcinoma. Immunohistochemical staining showed that pancreatic carcinoma cells were positive for granulocyte-colony stimulating factor. The patient developed interstitial pneumonia, probably caused by granulocyte-colony stimulating factor, and died 11 days after admission.</p> <p>Conclusion</p> <p>This is a rare case report of anaplastic pleomorphic-type carcinoma of the pancreas producing granulocyte-colony stimulating factor and confirmed by immunohistochemistry.</p

様々な物質とペプチドの複合体におけるナノ・バイオへの応用展開の検討

研究目的：近年、機能性中分子として注目されているペプチド （小タンパク質 を、さらに高機能化、多機能化させることを指向して、生体分子、無機化合物、有機小分子、高分子などと複合させた新規機能性複合体の創製を目的とする。また、これら複合体を用いたナノ分野やバイオ分野への応用展開の検討も行う 。研究概要：これまで分子単体では達成できなかったような高機能・多機能性の材料開発を目指し、無機化合物、有機小分子、高分子とペプチドを複合させた新規機能性複合体を創製する。その創製に際しては、近年、機能性中分子として注目されているペプチドを基に、ある機能を有するペプチドに、糖、核酸、酵素などの生体分子、有機合成小分子、合成高分子、無機化合物などをそれらと結合するペプチドリガンドを介して あるいは共有結合などで 複合させることで、従来以上 に 高機能化、多機能化 させた分子・複合体の創製 をねらう。さらに、本研究で作製できた複合体を用 いて、多段階触媒能を有する材料や、エレクトロニクス材料、特定疾病分子などを高度に検出できる素子、治療に役立つ薬剤などの開発につなげ、ナノ分野、バイオ分野への工学的な応用展開を検討する

Lung Adenocarcinoma Size Decrease after SARS-CoV-2 Vaccination during Long-Term Pembrolizumab Treatment: A Case Report

A man in his late 40s was diagnosed with clinical stage 4B lung adenocarcinoma with a PD-L1 tumor proportion score of 100% and high tumor mutational burden. A partial response was achieved after administration of pembrolizumab. The patient received two doses of a SARS-CoV-2 vaccine (BNT162b2) after 59 courses, and a chest computed tomography revealed consolidation in the peri-tumoral area, which subsequently disappeared, and the tumor continued to shrink in the next 4 months. This case provides indirect evidence for the persistence of cancer immunity during long-term treatment with immune checkpoint inhibitors and the potential for further activation

Reocclusion after Self-Expandable Metallic Stent Placement for Relieving Malignant Colorectal Obstruction as a Palliative Treatment

Self-expandable metallic stent (SEMS) placement has been practiced in several hospitals in Japan, including ours, since January 2012. Here, we report the case of an 82-year-old Japanese man who presented to the hospital with a 1-week history of right hypochondrial pain. Computed tomography (CT) findings indicated colorectal cancer. The laboratory findings on admission indicated severe anemia (red blood cell count, 426 × 104/μL; hemoglobin, 7.9 g/dL). We performed SEMS placement because the patient refused to undergo surgery. He did not attend any of the scheduled follow-up visits after SEMS placement. However, a year and a half after the SEMS placement, the patient attended the hospital because of difficulty in passing stool. A plain abdominal CT scan showed bowel reobstruction due to the ascending colon cancer after SEMS placement. We performed an emergency operation, ascending colostomy, on the same day. Colorectal stent placement may be a good treatment option for patients who refuse to undergo conventional therapeutic treatments or in those with unresectable colorectal cancer. Patients should be carefully followed up every few months after SEMS placement because of the risk of reocclusion